| |
| |
|
| Insider
Information: |
Drapeau Louis |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
48,934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,335,299 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,934 |
|
|
| Total
Value |
$1,335,299 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Executive Officer |
2005-05-02 |
14,934 |
2003-11-03 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Sr. VP Finance, CFO |
2007-05-14 |
6,000 |
2006-03-03 |
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2007-11-08 |
0 |
Premium* |
|
|
Insite Vision Inc |
INSV |
Vice President and CFO |
2015-10-28 |
0 |
2007-11-13 |
0 |
Premium* |
|
|
BioNovo Inc |
BNVIQ |
Director |
2010-10-19 |
18,000 |
|
0 |
Premium* |
|
|
Armata Pharmaceuticals, Inc |
ARMP |
Director |
2015-10-06 |
10,000 |
2015-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSV |
Insite Vision Inc |
Vice President and CFO |
• – – |
2015-10-28 |
4 |
D |
$0.35 |
$91,000 |
D/D |
(260,000) |
0 |
0 |
- |
|
| ARMP |
Armata Pharmaceuticals, I... |
Director |
– • – |
2015-10-06 |
4 |
B |
$4.39 |
$43,900 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-09-29 |
4 |
D |
$74.00 |
$555,000 |
D/D |
(7,500) |
0 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2014-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
7,500 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2012-06-04 |
4 |
A |
$10.10 |
$25,250 |
D/D |
2,500 |
4,500 |
0 |
- |
|
| INSV |
Insite Vision Inc |
Vice President and CFO |
• – – |
2011-07-18 |
4 |
B |
$0.60 |
$120,000 |
D/D |
200,000 |
260,000 |
2.74 |
- |
|
| INSV |
Insite Vision Inc |
Vice President and CFO |
• – – |
2011-05-27 |
4 |
A |
$0.89 |
$17,800 |
D/D |
20,000 |
60,000 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
Director |
– • – |
2010-10-19 |
4 |
B |
$0.97 |
$9,700 |
D/D |
10,000 |
18,000 |
2.39 |
- |
|
| BNVIQ |
BioNovo Inc |
Director |
– • – |
2008-12-01 |
4 |
B |
$0.38 |
$6,460 |
D/D |
17,000 |
40,000 |
2.39 |
- |
|
| BNVIQ |
BioNovo Inc |
Director |
– • – |
2008-11-28 |
4 |
B |
$0.35 |
$4,550 |
D/D |
13,000 |
23,000 |
2.31 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2008-08-06 |
4 |
B |
$17.45 |
$17,450 |
D/D |
1,000 |
2,000 |
2.39 |
- |
|
| BNVIQ |
BioNovo Inc |
Director |
– • – |
2008-03-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| INSV |
Insite Vision Inc |
VP, Chief Financial Officer |
• – – |
2008-02-29 |
4 |
B |
$0.78 |
$7,800 |
D/D |
10,000 |
40,000 |
2.74 |
- |
|
| INSV |
Insite Vision Inc |
VP, Chief Financial Officer |
• – – |
2007-11-13 |
4 |
A |
$1.17 |
$35,100 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2007-11-08 |
4 |
B |
$16.81 |
$16,810 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| NKTR |
Nektar Therapeutics |
Sr. VP Finance, CFO |
• – – |
2007-05-14 |
4 |
A |
$12.15 |
$12,150 |
D/D |
1,000 |
6,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
officerTitle |
• – – |
2007-03-05 |
4 |
B |
$11.77 |
$11,770 |
D/D |
1,000 |
5,000 |
2.74 |
- |
|
| NKTR |
Nektar Therapeutics |
Sr. VP Finance, CFO |
• – – |
2006-11-07 |
4 |
B |
$14.65 |
$14,650 |
D/D |
1,000 |
4,000 |
2.74 |
- |
|
| NKTR |
Nektar Therapeutics |
Sr. VP Finance, CFO |
• – – |
2006-08-08 |
4 |
B |
$16.35 |
$16,350 |
D/D |
1,000 |
3,000 |
2.74 |
- |
|
| NKTR |
Nektar Therapeutics |
Sr. VP Finance, CFO |
• – – |
2006-05-15 |
4 |
B |
$20.35 |
$20,350 |
D/D |
1,000 |
2,000 |
2.74 |
- |
|
| NKTR |
Nektar Therapeutics |
Sr. VP Finance, CFO |
• – – |
2006-03-03 |
4 |
B |
$20.08 |
$20,080 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• – – |
2005-05-02 |
4 |
A |
$3.43 |
$13,750 |
D/D |
4,004 |
14,934 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$12,943 |
D/D |
3,687 |
10,930 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
CFO, VP, Finance & Secretary |
• – – |
2004-05-03 |
4 |
A |
$5.70 |
$12,502 |
D/D |
2,192 |
7,243 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
CFO, Vice President, Finance |
• – – |
2003-11-03 |
4 |
A |
$5.70 |
$13,460 |
D/D |
2,360 |
5,051 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
